EU Pharma Rejects Proposed Changes To Orphan Medicine Criteria

Companies Want More Incentives For New Drug Development

 
• By Ian Schofield
3D illustration of REVISION script on road sign
The EU pediatric and orphan drug legislation is being revised. • Source: Alamy

More from Europe

More from Geography